Diana Boyko is currently the Global HEOR Director at Amgen, a position they have held since 2022 after serving as a Global Health Economics Manager from 2019 to 2022. Prior to joining Amgen, Diana worked as a Research Analyst at Policy Analysis Inc. from 2016 to 2019, where they developed HEOR cost-effectiveness models for cancer therapies. They began their career in management consulting as an Assistant Consultant at Management Solutions in 2015 and completed a Compliance Internship at Barclays Wealth Management in 2012. Diana holds both a Master’s and Bachelor's degree in Economics from Boston University, earned between 2010 and 2014.
This person is not in the org chart
This person is not in any teams
This person is not in any offices